eric topol glp-1 Topol: Drugs Reduce Substance Abuse Risk in Over 600,000 US Veterans GLP-1 drugs aren't just for
Description
Show your support for accessible healthcare and medical innovation.
Acquired conditions and genetic factors have been implicated in IR
A 2024 RCT found semaglutide reduced hip bone density by 2.6% and lumbar spine by 2.1% in one year
Insulin and incretins are compounds with multiple effects on neurodegenerative processes
Explore the benefits of our tirzepatide with b12 and glycine injection, formulated for appetite control and metabolic support.
Probiotics (50 Billion CFUs) Gut health + digestion support
